Malaria News and Research

Latest Malaria News and Research

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.

28 Nov 2012

Global Fund's new funding model 'designed to be flexible, focused, fast'

In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Todd Summers, senior adviser at the CSIS Global Health Policy Center, reviews the Global Fund to Fight AIDS, Tuberculosis and Malaria's old rounds-based grant system that the Global Fund Board recently agreed to replace with a new funding model "that's designed to be flexible, focused, and fast," he says.

28 Nov 2012

REEAD technology can diagnose malaria infections with very high sensitivity

Malaria is a life-threatening disease that strikes more than 200 million people every year - mainly in Africa, Asia and Latin America. The disease is caused by the Plasmodium parasite, which is spread by infected mosquito bites. Today, malaria can be prevented and successfully treated, but more than half a million people nevertheless die every year from the disease.

28 Nov 2012

Clinics on Cambodian-Thai border aim to prevent spread of drug-resistant malaria

BBC News examines "a worrying drop in the effectiveness of the artemisinin-based drugs" against malaria along the Cambodian-Thai border, and how clinics are attempting to combat the trend by offering monetary incentives to patients to complete treatment regimens.

27 Nov 2012

Avermectin family of drugs shows promise against TB

A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia microbiologists.

26 Nov 2012

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.

26 Nov 2012

DiscoGnosis project aims to develop rapid malaria test

An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.

22 Nov 2012

AMFm should continue, improvements should be explored

The "grand experiment" of the Affordable Medicines Facility-malaria (AMFm) -- a pilot program that aims to get artemisinin-based combination therapies (ACTs) into rural areas of several African nations -- "seems likely to end, its successes underrated and potential improvements not yet explored," a Nature editorial says.

22 Nov 2012

Incoming Global Fund head Mark Dybul says organization has 'strong forward trajectory'

The Global Fund to Fight AIDS, Tuberculosis and Malaria Board recently made several decisions that will affect the future of the organization, including appointing former U.S. Global AIDS Coordinator Ambassador Mark Dybul as executive director and adopting a new funding model, Nature reports in an article examining the history and future of the Fund.

22 Nov 2012

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help -- or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

21 Nov 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 202 of its "Global Fund Observer."

21 Nov 2012

Emory University, Georgia Tech to establish Malaria Host-Pathogen Interaction Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year contract of up to $19.4 million, depending on contract options exercised, to establish the Malaria Host-Pathogen Interaction Center (MaHPIC).

20 Nov 2012

UBC microbiologist receives Prix Galien 2012 Research Award

UBC microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honour in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unravelling the complex interactions between antibiotics and bacteria.

20 Nov 2012

Texas Biomed applies patent for new genetically-engineered vaccine strategy to prevent HIV

The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites of contact with the virus.

20 Nov 2012

International community must allocate resources to fund 'ambitious' Global Fund strategy against TB

Noting the Global Fund to Fight AIDS, Tuberculosis and Malaria met last week to discuss progress in fighting the three diseases, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, interviews Lucica Ditiu, executive secretary of the Stop TB Partnership, about the global response to tuberculosis (TB) in the Huffington Post's "The Big Push" blog.

20 Nov 2012

Scientists discover new mode of action for enzymes immersed in cellular membranes

Johns Hopkins scientists have discovered a new mode of action for enzymes immersed in cellular membranes. Their experiments suggest that instead of recognizing and clipping proteins based on sequences of amino acids, these proteases' location within membranes gives them the unique ability to recognize and cut proteins with unstable structures.

17 Nov 2012

Global Fund Board announces integration of AMFm into core grant system

The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday announced it will "integrate" the Affordable Medicines Facility-malaria (AMFm), implemented in 2010 as a pilot program to provide low-cost artemisinin-based combination therapies (ACTs) in poor and rural areas, "into its existing core system of providing grants to countries to purchase drugs, bed nets and other malaria-control measures," Nature News Blog reports.

17 Nov 2012

Interim results from RTS,S vaccine on-going phase III trial on malaria

According to the World Health Organization (WHO), more than 250 million clinical malaria cases are attributed to Plasmodium falciparum (Pf) annually, with over 1.1 million deaths in sub-Saharan Africa alone.

17 Nov 2012

Global Fund Board votes to begin immediate transition to new funding model

"In a bid to ensure the global fight against three of the world's most devastating diseases remains efficient, the Board of the ... Global Fund to Fight AIDS, Tuberculosis and Malaria voted Thursday to begin an immediate transition" to a new grant-funding approach, the U.N. News Centre reports.

17 Nov 2012

GlobalPost interviews PATH Malaria Control Program director about global response

In an interview with GlobalPost's "Global Pulse" blog, Kent Campbell, director of the Malaria Control Program at PATH, discusses "achievements in the fight against malaria and what is needed to bring transmission to zero."

17 Nov 2012

Malaria News and Research

Latest Malaria News and Research

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Global Fund's new funding model 'designed to be flexible, focused, fast'

REEAD technology can diagnose malaria infections with very high sensitivity

Clinics on Cambodian-Thai border aim to prevent spread of drug-resistant malaria

Avermectin family of drugs shows promise against TB

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

DiscoGnosis project aims to develop rapid malaria test

AMFm should continue, improvements should be explored

Incoming Global Fund head Mark Dybul says organization has 'strong forward trajectory'

Global health programs need to address community needs

Aidspan publishes new issue of 'Global Fund Observer'

Emory University, Georgia Tech to establish Malaria Host-Pathogen Interaction Center

UBC microbiologist receives Prix Galien 2012 Research Award

Texas Biomed applies patent for new genetically-engineered vaccine strategy to prevent HIV

International community must allocate resources to fund 'ambitious' Global Fund strategy against TB

Scientists discover new mode of action for enzymes immersed in cellular membranes

Global Fund Board announces integration of AMFm into core grant system

Interim results from RTS,S vaccine on-going phase III trial on malaria

Global Fund Board votes to begin immediate transition to new funding model

GlobalPost interviews PATH Malaria Control Program director about global response

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in